Co-Authors
This is a "connection" page, showing publications co-authored by Vincent Cheng and Yi Guan.
Connection Strength
0.146
-
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol. 2005 Nov; 12(11):1317-21.
Score: 0.020
-
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis. 2005 Dec 01; 192(11):1898-907.
Score: 0.020
-
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004 Sep; 31(1):69-75.
Score: 0.019
-
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet. 2004 Mar 13; 363(9412):841-5.
Score: 0.018
-
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar; 59(3):252-6.
Score: 0.018
-
Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004 Feb; 10(2):294-9.
Score: 0.018
-
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24; 361(9371):1767-72.
Score: 0.017
-
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003 Apr 19; 361(9366):1319-25.
Score: 0.017